Rate and Predictors of Permanent Pacemaker Implantation after Transcatheter Aortic Valve Implantation: Current Status

E Russo, D R Potenza, M Casella, R Massaro, G Russo, M Braccio, A Dello Russo, M Cassese

Research output: Contribution to journalArticle

Abstract

Transcather aortic valve implantation (TAVI) has become a safe and indispensable treatment option for patients with severe symptomatic aortic stenosis who are at high surgical risk. Recently, outcomes after TAVI have improved significantly and TAVI has emerged as a qualified alternative to surgical aortic valve replacement in the treatment of intermediate risk patients and greater adoption of this procedure is to be expected in a wider patients population, including younger patients and low surgical risk patients. However since the aortic valve has close spatial proximity to the conduction system, conduction anomalies are frequently observed in TAVI. In this article, we aim to review the key aspects of pathophysiology, current incidence, predictors and clinical association of conduction anomalies following TAVI.

Original languageEnglish
JournalCurrent Cardiology Reviews
DOIs
Publication statusE-pub ahead of print - Dec 4 2018

Fingerprint

Aortic Valve
Aortic Valve Stenosis
Transcatheter Aortic Valve Replacement
Surgical Instruments
Incidence
Therapeutics
Population

Cite this

Rate and Predictors of Permanent Pacemaker Implantation after Transcatheter Aortic Valve Implantation : Current Status. / Russo, E; Potenza, D R; Casella, M; Massaro, R; Russo, G; Braccio, M; Dello Russo, A; Cassese, M.

In: Current Cardiology Reviews, 04.12.2018.

Research output: Contribution to journalArticle

@article{c7c9b1cbe25642b6923e5ea42a07a037,
title = "Rate and Predictors of Permanent Pacemaker Implantation after Transcatheter Aortic Valve Implantation: Current Status",
abstract = "Transcather aortic valve implantation (TAVI) has become a safe and indispensable treatment option for patients with severe symptomatic aortic stenosis who are at high surgical risk. Recently, outcomes after TAVI have improved significantly and TAVI has emerged as a qualified alternative to surgical aortic valve replacement in the treatment of intermediate risk patients and greater adoption of this procedure is to be expected in a wider patients population, including younger patients and low surgical risk patients. However since the aortic valve has close spatial proximity to the conduction system, conduction anomalies are frequently observed in TAVI. In this article, we aim to review the key aspects of pathophysiology, current incidence, predictors and clinical association of conduction anomalies following TAVI.",
author = "E Russo and Potenza, {D R} and M Casella and R Massaro and G Russo and M Braccio and {Dello Russo}, A and M Cassese",
note = "Copyright{\circledC} Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.",
year = "2018",
month = "12",
day = "4",
doi = "10.2174/1573403X15666181205105821",
language = "English",
journal = "Current Cardiology Reviews",
issn = "1573-403X",
publisher = "Bentham Science Publishers B.V.",

}

TY - JOUR

T1 - Rate and Predictors of Permanent Pacemaker Implantation after Transcatheter Aortic Valve Implantation

T2 - Current Status

AU - Russo, E

AU - Potenza, D R

AU - Casella, M

AU - Massaro, R

AU - Russo, G

AU - Braccio, M

AU - Dello Russo, A

AU - Cassese, M

N1 - Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

PY - 2018/12/4

Y1 - 2018/12/4

N2 - Transcather aortic valve implantation (TAVI) has become a safe and indispensable treatment option for patients with severe symptomatic aortic stenosis who are at high surgical risk. Recently, outcomes after TAVI have improved significantly and TAVI has emerged as a qualified alternative to surgical aortic valve replacement in the treatment of intermediate risk patients and greater adoption of this procedure is to be expected in a wider patients population, including younger patients and low surgical risk patients. However since the aortic valve has close spatial proximity to the conduction system, conduction anomalies are frequently observed in TAVI. In this article, we aim to review the key aspects of pathophysiology, current incidence, predictors and clinical association of conduction anomalies following TAVI.

AB - Transcather aortic valve implantation (TAVI) has become a safe and indispensable treatment option for patients with severe symptomatic aortic stenosis who are at high surgical risk. Recently, outcomes after TAVI have improved significantly and TAVI has emerged as a qualified alternative to surgical aortic valve replacement in the treatment of intermediate risk patients and greater adoption of this procedure is to be expected in a wider patients population, including younger patients and low surgical risk patients. However since the aortic valve has close spatial proximity to the conduction system, conduction anomalies are frequently observed in TAVI. In this article, we aim to review the key aspects of pathophysiology, current incidence, predictors and clinical association of conduction anomalies following TAVI.

U2 - 10.2174/1573403X15666181205105821

DO - 10.2174/1573403X15666181205105821

M3 - Article

C2 - 30516109

JO - Current Cardiology Reviews

JF - Current Cardiology Reviews

SN - 1573-403X

ER -